Suppr超能文献

肾髓质集合管细胞中的特异性内皮素结合位点:与心钠素结合及环磷酸鸟苷信号传导无相互作用。

Specific endothelin binding sites in renal medullary collecting duct cells: lack of interaction with ANP binding and cGMP signalling.

作者信息

Cernacek P, Legault L, Stewart D J, Levy M

机构信息

Department of Medicine, McGill University, Montréal, Qué., Canada.

出版信息

Can J Physiol Pharmacol. 1992 Aug;70(8):1167-74. doi: 10.1139/y92-162.

Abstract

The diverse biological actions of endothelins (ET) appear to be mediated by specific cell-surface receptors. Autoradiography and membrane binding studies have shown abundant ET binding sites in the kidney. However, their expression in specific types of renal cells is unclear. We studied the binding of 125I-labelled endothelin-1 in freshly isolated cell suspensions from canine inner medullary collecting duct. Competition binding experiments revealed the presence of specific high-affinity binding sites: unlabelled ET-1 and ET-2 compared with the radioligand with an IC50 of 135 and 83 pM, respectively, while the IC50 of ET-3 and big ET-1 were 2 and 4 orders of magnitude higher, indicating the presence of ETA-type receptor. Angiotensin II, vasopressin, and atrial natriuretic peptide (ANP) did not compete for ET binding even at a concentration of 10(-6) M. Saturation binding experiments showed a single class of binding sites of high density (Bmax = 56.7 +/- 10.3 fmol/10(6) cells) and high affinity (Kd = 69.8 +/- 10 pM). In contrast, ANP receptors in the same cell preparations appeared as two classes of binding sites with widely different affinity and density. The high-affinity ANP site (Kd = 311 +/- 48 pM) was compatible with ANP-B (guanylate cyclase-coupled) receptor. ET-1 did not compete for this receptor. ET-1 (10(-7) M) did not alter ANP-induced cGMP generation in these cells (3.8-fold increase at 10(-7) M ANP), nor basal levels of cGMP.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

内皮素(ET)多样的生物学作用似乎是由特定的细胞表面受体介导的。放射自显影和膜结合研究表明,肾脏中存在丰富的ET结合位点。然而,它们在特定类型肾细胞中的表达尚不清楚。我们研究了125I标记的内皮素-1在犬肾内髓集合管新鲜分离的细胞悬液中的结合情况。竞争结合实验显示存在特异性高亲和力结合位点:未标记的ET-1和ET-2与放射性配体竞争时,IC50分别为135和83 pM,而ET-3和大内皮素-1的IC50高2至4个数量级,表明存在ETA型受体。即使在浓度为10^(-6) M时,血管紧张素II、血管加压素和心房利钠肽(ANP)也不与ET结合竞争。饱和结合实验显示存在一类高密度(Bmax = 56.7 ± 10.3 fmol/10^6细胞)和高亲和力(Kd = 69.8 ± 10 pM)的结合位点。相比之下,相同细胞制剂中的ANP受体表现为两类亲和力和密度差异很大的结合位点。高亲和力ANP位点(Kd = 311 ± 48 pM)与ANP-B(鸟苷酸环化酶偶联)受体相符。ET-1不与该受体竞争。ET-1(10^(-7) M)不会改变这些细胞中ANP诱导的cGMP生成(在10^(-7) M ANP时增加3.8倍),也不会改变cGMP的基础水平。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验